Gang Song

Gang Song has over 20 years of experience in the biotechnology industry. In 2021, they were Co-Founder and Founding CEO of Immu(no)racle Inc. From 2017 to 2021, they were an Operating Partner at ORI Capital. From 2016 to 2017, they were Co-Founder of AffyImmune Therapeutics. From 2014 to 2016, they were Chairman of the Board, Founder, President and CEO of Pillar Biosciences Incorporated. From 2013 to 2014, they were Founder of Pillar Biosciences LLC. From 2010 to 2013, they were a Staff Scientist/Technical Lead at Integrated Genetics (Successor to Genzyme Genetics), LabCorp. From 2007 to 2010, they were a Research Scientist/Project Manager at IQuum (now Roche). From 2001 to 2007, they were a Postdoctoral Research Fellow at Harvard Medical School.

Gang Song attended Shanghai Medical College of Fudan University and Tianyi High School.